the attempts to secure protection under these circumstances with the utilization of amodiaquine , the combination of sulfadoxine/pyrimethamine ( fansidar ) , sulfalene/pyrimethamine ( metakelfin ) , of pyrimethamine/dapsone ( maloprim ) , with or without chloroquine , had to be abandoned or to be used with caution in view of the severe complications following the weekly administration of these drugs .
C0700599
sulfadoxine/pyrimethamine
C0060061
fansidar